Triptorelin Acetate (GnRH)

$24.00

Full Name: Triptorelin Acetate
Alternative Name: Triptorelin Acetate Salt / GnRH Analogue
CAS #: 140194-24-7
Molecular Formula: C₆₆H₈₆N₁₈O₁₅
Molecular Weight (M.W.): Approximately 1371.5 g/mol
Sequence: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ · Acetic Acid
One-Letter Sequence: XHWSYWLRPG
Length: 10 amino-acid-derived residues
Product Type: Modified Synthetic Research Decapeptide Acetate

Triptorelin Acetate is a modified synthetic decapeptide supplied for controlled laboratory and analytical research. It is structurally related to gonadotropin-releasing hormone and contains defined modifications that distinguish it from the native peptide sequence.

Its structure includes an N-terminal pyroglutamyl residue, a D-tryptophan residue, C-terminal amidation, and association with acetic acid in the acetate form.

PubChem lists Triptorelin Acetate with CAS 140194-24-7, molecular formula C₆₆H₈₆N₁₈O₁₅, molecular weight approximately 1371.5 g/mol, and sequence representation H-Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂·CH₃CO₂H.

Research Applications

Triptorelin Acetate may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Ligand-receptor interaction studies
  • GnRH-related molecular signaling research
  • Structure-function analysis
  • Stereochemistry-focused peptide studies
  • Analytical peptide comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Any findings should remain limited to the applicable experimental system and should not be interpreted as evidence of therapeutic, reproductive, hormonal, endocrine, or clinical effectiveness.

Structural Information

Triptorelin Acetate is commonly represented as:

pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ · CH₃CO₂H

Important structural features include:

  • N-terminal pyroglutamic acid
  • D-tryptophan substitution
  • C-terminal glycinamide
  • Acetate association

PubChem abbreviates the peptide sequence as XHWSYWLRPG, where the initial X represents the pyroglutamyl residue in the database sequence notation.

Analytical Identification

Relevant analytical characterization may include:

  • Peptide identity confirmation
  • Amino-acid sequence verification
  • D-residue stereochemistry confirmation
  • Molecular mass assessment
  • Acetate-form verification
  • Chromatographic purity testing
  • Structural characterization
  • Lot-specific quality analysis

Because Triptorelin free base and Triptorelin Acetate are chemically distinct forms, their molecular formula and molecular weight should not be used interchangeably.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Compound identity
  • Peptide sequence
  • Acetate form
  • Molecular formula
  • Molecular weight
  • Stereochemical configuration
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific analytical documentation should take precedence over generalized reference data.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for research materials.

Research Use Only

Triptorelin Acetate is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, reproductive or hormonal use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, endocrine, reproductive, hormonal, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.